SCIderm

Hamburg, Germany Founded: 2005 • Age: 21 yrs Acquired By TFS
CRO focussed exclusively in dermatology, allergology, aesthetic drug development and device certification services
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About SCIderm

SCIderm is a company based in Hamburg (Germany) founded in 2005 was acquired by TFS in October 2016. SCIderm operates in a competitive market with competitors including Therapeutics, Innovaderm, SIT Skin Investigation and Technology, Cu-Tech and Bioskin, among others.

  • Headquarter Hamburg, Germany
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    TFS

    (Oct 07, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of SCIderm

Premium access

Detailed funding history for SCIderm

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in SCIderm

SCIderm has secured backing from 1 investor. Prominent investors backing the company include TFSCRO.

All
Investor Description Founded Year Domain Location
Clinical research services are provided globally by TFS CRO.
Locked Locked Locked
Premium access

Investor details for SCIderm

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SCIderm

Investments
Premium access

Investment portfolio details for SCIderm

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - SCIderm

Premium access

Detailed financials for SCIderm

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sciderm Comparisons

SCIderm Primary company
Description
CRO focussed exclusively in dermatology, allergology, aesthe...
Location
Hamburg, Germany
Founded Year
2005
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for SCIderm

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of SCIderm

SCIderm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Therapeutics, Innovaderm, SIT Skin Investigation and Technology, Cu-Tech and Bioskin, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Dermatology-focused CRO services for drugs, biologics, and devices are provided.
Locked Locked Locked
Conducts clinical trials for dermatology research and patient care services.
Locked Locked Locked
Provides skin research, testing, and clinical studies for cosmetic and chemical sectors.
Locked Locked Locked
Full-service dermatology CRO for Phase I-IV clinical trials is operated.
Locked Locked Locked
Dermatology CRO offering clinical trial services for drugs, medical devices, food supplements and advanced cosmetics
Locked Locked Locked
Operates as a contract research organization, delivering specialized research services.
Premium access

Detailed competitors of SCIderm

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sciderm

Premium access

Complete news archive for SCIderm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SCIderm

SCIderm was founded in 2005.

SCIderm is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.

SCIderm was a Germany based CRO exclusively focussed on dermatology related drug and device development, which was acquired by TFS, a mid tier CRO in October 2016. SCIderm had access to key opinion leaders and over 350 investigational sites in Europe and North America for the conduct of dermatology clinical trials at the time of acquisition. SCIderm had and continues to have close ties with the Dermatologikum Clinic in Hamburg, which apart from offering clinical development services for new therapy treatments in allergology, dermatology and aesthetics, also offers laboratory services in histology, mycology, bacteriology, molecular biology and quantitative RNA analysis identifying pathways of molecules and proves the mode-of-action in the early development stages.

SCIderm's top competitors include Therapeutics, Cu-Tech and Hill Top Research.

SCIderm has 1 investor. Key investors include TFSCRO.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available